SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 6

QT ve P dalga dispersiyonu üzerine Gilbert sendromunun etkisi: Gözlemsel bir çalışma

The effect of Gilbert’s syndrome on the dispersions of QT interval and P-wave: an observational study

Yüksel ÇİÇEK
Erkan CÜRE
Süleyman YÜCE
Medine Cumhur CÜRE
Pages
559–565
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Pd of patients group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gilbert’s syndrome (GS) decreases the incidence of atherosclerotic heart disease.
📊
Key Findings & Data:Methods: Sixty-one patients diagnosed with GS (31 females, 30 males) who had applied to the internal medicine outpatient clinic in the hospital were included in this cross-sectional, observational study.
💡
Conclusion & Impact:The Pd of patients group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Gilbert’s syndrome (GS) decreases the incidence of atherosclerotic heart disease. The aim of the study was to evaluate whether the arrhythmia risk markers such as P-wave dispersion (Pd), QT dispersion (QTd) are reduced in patients with GS compared with healthy subjects. Methods: Sixty-one patients diagnosed with GS (31 females, 30 males) who had applied to the internal medicine outpatient clinic in the hospital were included in this cross-sectional, observational study. A control group of 61 healthy persons (31 females, 30 males), who were non-smokers and drinkers, were included. Both groups were between 16-45 years old. Results of anthropometric measurements, laboratory assays and electrocardiographic findings were recorded for each participant. Independent sample t-test and nested ANOVA were used for data analysis. Results: In the GS group were Pd value 36±16.7 msec, QTd 48.7±10.7 msec and heart rate (HR) 74±8 beat/min. In the control group were Pd 51±28 msec, QTd 53±12 msec and HR 78±10 beat/min. The Pd of patients group (p

Özet

Amaç: Gilbert sendromu (GS) aterosklerotik kalphastalığı sıklığını azaltır. Bu çalışmanın amacı P dalga dispersiyonu (Pd), QT dispersiyonu (QTd) gibi aritmi risk belirteçlerinin sağlıklı bireylerle kıyaslandığında GS’li hastalarda azalmış olup olmadığını değerlendirmektir. Yöntemler: Hastanemiz iç hastalıkları polikliniğine başvuran toplam 61 GS hastası (31 kadın, 30 erkek) kesitsel gözlemsel bu çalışmaya dahil edildi. Sigara içmeyen 61 sağlıklı (31 kadın, 30 erkek) kişi çalışmaya alındı. İki grup da 16-45 yaş grubu arasındaydı. Antropometrik ölçümler, laboratuvar ve elektrokardiyografik bulguların sonuçları her katılımcı için kaydedildi. Veri analizi için bağımsız örneklem t-testi ve kümelenmiş ANOVA kullanıldı. Bulgular: GS grubunda Pd 36±16,7 msec, QTd 48,7±10,7 msec ve kalp hızı (KH) 74±8 atım/dk idi. Kontrol grubunda Pd 51±28 msec, QTd 53±12 msec ve KH 78±10 atım/dk idi. Hasta grubunda Pd (p

🔖

Cite This Article

ÇİÇEK, Y., CÜRE, E., YÜCE, S., CÜRE, M. C. (2022). QT ve P dalga dispersiyonu üzerine Gilbert sendromunun etkisi: Gözlemsel bir çalışma. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 6, 559–565. https://ajindex.com/articles/436197

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bosma PJ. Inherited disorders of bilirubin metabolism.J Hepatol 2003
  2. [CrossRef] 2. Fertrin KY, Goncalves MS, Saad ST, Costa FF. Frequencies of UDP- glucuronosyl transferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet 2002
  3. [CrossRef] 3. Strassburg CP Hyperbilirubinemia syndromes (Gilbert- Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol 2010
  4. [CrossRef] Hirschfield GM, Alexander GJ. Gilbert's syndrome: an overview for clinical biochemists. Ann ClinBiochem 2006
  5. [CrossRef] 4. Hirschfield GM, Alexander GJ. Gilbert's syndrome: an overview for clinical biochemists. Ann ClinBiochem 2006
  6. [CrossRef] 5. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2007
  7. [CrossRef] 6. Cranefield PF, Wit AL, Hoffman BF. Genesis of cardiac arrhythmias. Circulation 1973
  8. [CrossRef] 7. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008
  9. [CrossRef] 8. Tapan S, Karadurmuş N, Doğru T, Erçin CN, Taşcı I, Bilgi C, et al. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem 2011
  10. [CrossRef] 9. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 2008
  11. [CrossRef] 10. Michelucci A, Bagliani G, Colella A, Pieragnoli P Porciani MC, Gensini G, et al. P wave assessment: State of the art update. Card Electrophysiol Rev 2002
  12. [CrossRef] 11. Magnani JW, Johnson VM, Sullivan LM, Lubitz SA, Schnabel RB, Ellinor PT, et al. P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol 2010
  13. [CrossRef] 12. Ding LG, Hua W, Chu JM, Qiao Q, Chen KP Wang FZ, et al. Improvement of P-wave dispersion is associated with a lower incidence of atrial fibrillation after cardiac resynchronization therapy. Chin Med J 2012
  14. Day CP McComb JM, Campbell RW. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990
  15. [CrossRef] 14. Bluzaite I, Brazdzionyte J, Zaliünas